HCP Live

Rheumatoid Arthritis Quiz: Drug-Free Remission

Dec 7, 2021

Ingrid Torjesen

Rheumatoid arthritis often requires long-term treatment with disease-modifying antirheumatic drugs (DMARDs), but tapering and even cessation of DMARDs can be considered for patients in remission. Test your knowledge of use of DMARDs in patients in remission with this quiz.

Is the following statement true or false?

The American College of Rheumatology recommends an initial treatment goal of remission in patients with early rheumatoid arthritis.

Related Videos

Balancing COVID-19 Risk and Wellness in Patients with Rheumatic Diseases

Exploring Patient Experiences, Challenges of Rheumatic Disease Management During the Pandemic

Brian LaMoreaux, MD | Credit: Horizon Therapeutics

Natalie McCormick, PhD | Credit: American College of Rheumatology

Brian LaMoreaux, MD | Credit: Horizon Therapeutics

Related Content

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Related Content

George Karpouzas, MD | Credit: Lundquist Institute

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Shilpa Venkatachalam, PhD, MPH | Credit: Global Healthy Living Foundation

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

Natalie McCormick, PhD | Credit: American College of Rheuamtology

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

A pregnant woman having a discussion with their doctor | Credit: Mart Production - Pexels

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.